Product image of Ztalmy (Ganaxolone) supplied by GNH India

Ztalmy

Active Ingredient:
Ganaxolone
Origin:
EU

Ztalmy (Ganaxolone)

Ztalmy (ganaxolone) is an oral medication used for seizure management. This anticonvulsant supports neurological stability in specific epilepsy types. Ganaxolone is a neuroactive steroid with a broad therapeutic profile. Suitable for patients requiring adjunctive therapy for seizures.

Manufacturer / TM Owner

Immedica Pharma Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Ztalmy (ganaxolone) is prescribed as an add-on treatment for seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder. It is also used for managing focal seizures in adults. Ganaxolone works by modulating GABA receptors to reduce hyperexcitability in the brain. This medication is designed for patients who have not responded adequately to other antiepileptic drugs.

Side Effects

  • Ganaxolone may help reduce the frequency and severity of seizures over time. Users often report improved daily functioning as seizure activity decreases. Some individuals experience drowsiness or dizziness, particularly when starting treatment. These effects typically lessen as the body adjusts to the medication.

Precautions & Warnings

  • Store ganaxolone at room temperature away from moisture and heat. Keep this medication in its original packaging until ready to use. Always follow the prescribed schedule and do not adjust doses without consulting a healthcare provider. Report any unusual changes in mood or behavior to a medical professional promptly.

Avoid Interactions

  • Ganaxolone may interact with central nervous system depressants, including alcohol and sedatives. Caution is advised when combining with other antiepileptic drugs or medications affecting GABA receptors. CYP3A4 inhibitors or inducers can alter ganaxolone levels, requiring dose adjustments. Always disclose all current medications to your healthcare provider before starting ganaxolone.

Frequently Asked Questions

Ztalmy is used as an add-on therapy for seizures linked to CDKL5 deficiency disorder and focal seizures in adults.

Ganaxolone is taken orally as directed by a healthcare provider, typically with food to improve absorption.

Common side effects may include drowsiness, dizziness, or fatigue, especially when starting treatment.

Ganaxolone may interact with other drugs; consult a healthcare provider to review all current medications before use.

Long-term safety depends on individual health factors; regular monitoring by a healthcare provider is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ganaxolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT